A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis

NCT00293826 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

813

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: AMG 108
DRUG: AMG 108
DRUG: AMG 108
DRUG: Placebo

Sponsor

Amgen